Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 June 4, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Prev Post 5 Biggest Blockchain ETFs in 2025 June 4, 2025 Next Post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case June 4, 2025 Related Posts Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026 February 7, 2026 Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve “Project Vault” and Highlights Titanium’s Strategic Importance to North American Defense Supply Chains February 7, 2026 After Major Gold Payout, Bian Ximing Turns Bearish Sights on Silver February 7, 2026
Blackrock Silver to Present at the Precious Metals and Critical Minerals Virtual Investor Conference on February 10th 2026 February 7, 2026
Saga Metals Acknowledges U.S. Strategic Critical Minerals Reserve “Project Vault” and Highlights Titanium’s Strategic Importance to North American Defense Supply Chains February 7, 2026
